最新文章：伊维菌素和甲苯咪唑的见证——一位来自伊利诺伊州芝加哥的60岁多发性骨髓

最新文章：伊维菌素和甲苯咪唑的见证——一位来自伊利诺伊州芝加哥的60岁多发性骨髓瘤患者在服用一年后汇报情况！🚨警告——这个故事“没有化疗”，我再说一遍，这个故事“没有化疗”。请前往最近的安全地点，蜷缩成胎儿的姿势开始哭泣。一名60岁的伊利诺伊州芝加哥市女性患有多发性骨髓瘤我的早期客户之一，于 2024 年 11 月开始：伊维菌素 66毫克/天甲苯咪唑 1500 毫克/天“我接受您提供的治疗多发性骨髓瘤的方案已经一年了。”“我的M蛋白水平保持稳定，而我的Kappa/Lambda轻链数量再次有所改善。”主流肿瘤学和 250 亿美元的癌症研究经费告诉我们，以上情况是不可能的。你能想象吗！美国国家癌症研究所2015年至2024年间投入超过250亿美元用于癌症研究，竟然连这个都没发现？所有这些浪费在癌症研究上的钱都白花了……NEW ARTICLE: IVERMECTIN and MEBENDAZOLE Testimonial - 60 year old Chicago, Illinois woman with Multiple Myeloma reports after 1 year!🚨Warning - this story has "no chemo", I repeat, this story has "no chemo". Proceed to the nearest safe space and assume fetal position to commence crying.60 year old Chicago, Illinois woman with Multiple MyelomaOne of my earliest clients, in November 2024 she started:Ivermectin 66mg/dayMebendazole 1500mg/day"It has been one year since I have been on your protocol for treating my multiple myeloma""My M protein has remained constant and my Kappa/Lambda Light chain numbers have once again improved"Mainstream Oncology and $25 billion in Cancer Research tells us the above is IMPOSSIBLE.Can you imagine! National Cancer Institute invested over $25 billion into Cancer Research between 2015-2024 and they couldn't even stumble upon THIS?All that wasted Cancer Research money for nothing...